Clinical Trials List
2023-08-01 - 2027-04-30
Phase I
Recruiting4
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Kai-Ling Lee Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Pai-Chien Chou Division of Thoracic Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 林昭文 Division of Ophthalmology
- 許嘉林 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- Jih-Hsiang Lee Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Hung Luo Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
240 participants